Translating next-generation sequencing from clinical trials to clinical practice for the treatment of advanced cancers

Personalized Medicine
Kristen R Dearing, Glen J Weiss

Abstract

Next-generation sequencing (NGS) is being applied in oncology care to identify specific molecular aberrations of patient's tumors. The use of NGS now allows for sequencing entire human genomes within a reasonable cost and practical time frames for treatment decision making. Further delineation of epigenetics, transcriptomics, metagenomics and NGS at the level of circulating tumor DNA reveal ever increasing complexity to understand these interactions and the roles they play in cancer. With the improvement in understanding the study of proteomics, it has become clear that NGS has room for innovation to someday include sequencing of proteins. Early embarkation of NGS incorporated into clinical trials has begun. Here, we review the feasibility and practicality of translating NGS from clinical trials to clinical practice.

References

Mar 24, 2004·Current Opinion in Chemical Biology·Ole Nørregaard Jensen
Mar 18, 2005·Cancer Genetics and Cytogenetics·Tingxi YuDavid I Smith
May 7, 2005·Nature Biotechnology·George L Gabor Miklos
Nov 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marissa N BalakWilliam Pao
Feb 27, 2007·Cell·Peter A Jones, Stephen B Baylin
Oct 8, 2009·Human Molecular Genetics·Elaine R Mardis, Richard K Wilson
Jun 4, 2010·Briefings in Bioinformatics·Daniel C KoboldtRichard K Wilson
Jan 1, 2009·Human Genomics and Proteomics : HGP·Kondethimmanahalli Chandramouli, Pei-Yuan Qian
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
Nov 15, 2011·Breast Cancer Research : BCR·Yi HuangSteffi Oesterreich
Dec 3, 2011·Science Translational Medicine·Sameek RoychowdhuryArul M Chinnaiyan
Sep 6, 2012·International Journal of Cancer. Journal International Du Cancer·Ben TranJanet E Dancey
Nov 10, 2012·Nature Biotechnology·Amy S GargisIra M Lubin
Feb 2, 2013·Clinical Journal of Oncology Nursing·Erica Glass, Pamela Hallquist Viale
Mar 15, 2013·The New England Journal of Medicine·Sarah-Jane DawsonNitzan Rosenfeld
Apr 9, 2013·Annual Review of Analytical Chemistry·Elaine R Mardis
Apr 20, 2013·The American Journal of Surgical Pathology·Robert T SweeneyRobert B West
May 3, 2013·Expert Review of Clinical Immunology·Shirin MoossaviNima Rezaei
Jul 3, 2013·The Journal of Molecular Diagnostics : JMD·David H SpencerEric J Duncavage
Aug 2, 2013·Journal of Nanoscience and Nanotechnology·Yongqiang YangYiyu Zhang
Sep 28, 2013·Nucleic Acids Research·Winnie S LiangDavid W Craig
Oct 1, 2013·Cell·Daniel C KoboldtElaine R Mardis
Oct 29, 2013·FEBS Letters·Chrisann Kyi, Michael A Postow
Nov 21, 2013·Molecular Cancer Therapeutics·Jakob AlbrethsenChia-Ping Huang Yang
Nov 26, 2013·Frontiers in Immunology·Markus ChmielewskiHinrich Abken
Dec 12, 2013·Environmental and Molecular Mutagenesis·Klaas MensaertTim De Meyer
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Zsofia K StadlerKenneth Offit
Mar 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stacy W GrayJane C Weeks
Apr 30, 2014·Frontiers in Immunology·Theofilos PoutahidisSusan E Erdman
May 23, 2014·JAMA : the Journal of the American Medical Association·Mark G KrisPaul A Bunn

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
chromosomal aberrations
whole genome shotgun sequencing
genetic modifications
biopsy
proteomic sequencing
genotyping
xenografts
PCR

Clinical Trials Mentioned

NCT01050296
NCT01118078
NCT01851213
NCT01566279
NCT02112357
NCT01946100
NCT01856296
NCT02071719
NCT01939847

Software Mentioned

Nex
StoCT

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.